Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1996 Apr;34(4):980–982. doi: 10.1128/jcm.34.4.980-982.1996

Host DNA can interfere with detection of Borrelia burgdorferi in skin biopsy specimens by PCR.

F B Cogswell 1, C E Bantar 1, T G Hughes 1, Y Gu 1, M T Philipp 1
PMCID: PMC228932  PMID: 8815123

Abstract

It is demonstrated that a diagnostic PCR for Borrelia burgdorferi can be inhibited in the presence of more than 500 ng of host (monkey skin) DNA. The inhibitor is the host DNA itself. An acceptable value for analytical sensitivity can be obtained by diluting the skin-B. burgdorferi proteinase K lysate to a level below the inhibitory concentration of the host DNA. Dilution of the lysate may obviate the need for further DNA purification.

Full Text

The Full Text of this article is available as a PDF (271.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Chavira R., Jr, Burnett T. J., Hageman J. H. Assaying proteinases with azocoll. Anal Biochem. 1984 Feb;136(2):446–450. doi: 10.1016/0003-2697(84)90242-2. [DOI] [PubMed] [Google Scholar]
  2. Goodman J. L., Bradley J. F., Ross A. E., Goellner P., Lagus A., Vitale B., Berger B. W., Luger S., Johnson R. C. Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction. Am J Med. 1995 Jul;99(1):6–12. doi: 10.1016/s0002-9343(99)80097-7. [DOI] [PubMed] [Google Scholar]
  3. Kitten T., Barbour A. G. The relapsing fever agent Borrelia hermsii has multiple copies of its chromosome and linear plasmids. Genetics. 1992 Oct;132(2):311–324. doi: 10.1093/genetics/132.2.311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Kuiper H., van Dam A. P., Spanjaard L., de Jongh B. M., Widjojokusumo A., Ramselaar T. C., Cairo I., Vos K., Dankert J. Isolation of Borrelia burgdorferi from biopsy specimens taken from healthy-looking skin of patients with Lyme borreliosis. J Clin Microbiol. 1994 Mar;32(3):715–720. doi: 10.1128/jcm.32.3.715-720.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Moter S. E., Hofmann H., Wallich R., Simon M. M., Kramer M. D. Detection of Borrelia burgdorferi sensu lato in lesional skin of patients with erythema migrans and acrodermatitis chronica atrophicans by ospA-specific PCR. J Clin Microbiol. 1994 Dec;32(12):2980–2988. doi: 10.1128/jcm.32.12.2980-2988.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Persing D. H., Rutledge B. J., Rys P. N., Podzorski D. S., Mitchell P. D., Reed K. D., Liu B., Fikrig E., Malawista S. E. Target imbalance: disparity of Borrelia burgdorferi genetic material in synovial fluid from Lyme arthritis patients. J Infect Dis. 1994 Mar;169(3):668–672. doi: 10.1093/infdis/169.3.668. [DOI] [PubMed] [Google Scholar]
  7. Philipp M. T., Aydintug M. K., Bohm R. P., Jr, Cogswell F. B., Dennis V. A., Lanners H. N., Lowrie R. C., Jr, Roberts E. D., Conway M. D., Karaçorlu M. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect Immun. 1993 Jul;61(7):3047–3059. doi: 10.1128/iai.61.7.3047-3059.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Ranki A., Aavik E., Peterson P., Schauman K., Nurmilaakso P. Successful amplification of DNA specific for Finnish Borrelia burgdorferi isolates in erythema chronicum migrans but not in circumscribed scleroderma lesions. J Invest Dermatol. 1994 Mar;102(3):339–345. doi: 10.1111/1523-1747.ep12371793. [DOI] [PubMed] [Google Scholar]
  9. Roberts E. D., Bohm R. P., Jr, Cogswell F. B., Lanners H. N., Lowrie R. C., Jr, Povinelli L., Piesman J., Philipp M. T. Chronic lyme disease in the rhesus monkey. Lab Invest. 1995 Feb;72(2):146–160. [PubMed] [Google Scholar]
  10. Salinas-Meléndez J. A., Tamez-González R., Welsh-Lozano O., Barrera-Saldaãna H. A. Detection of Borrelia burgdorferi DNA in human skin biopsies and dog synovial fluid by the polymerase chain reaction. Rev Latinoam Microbiol. 1995 Jan-Mar;37(1):7–10. [PubMed] [Google Scholar]
  11. Schempp C., Bocklage H., Lange R., Kölmel H. W., Orfanos C. E., Gollnick H. Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification. J Invest Dermatol. 1993 May;100(5):717–720. doi: 10.1111/1523-1747.ep12472369. [DOI] [PubMed] [Google Scholar]
  12. Wienecke R., Neubert U., Volkenandt M. Molecular detection of Borrelia burgdorferi in formalin-fixed, paraffin-embedded lesions of Lyme disease. J Cutan Pathol. 1993 Oct;20(5):385–388. doi: 10.1111/j.1600-0560.1993.tb00658.x. [DOI] [PubMed] [Google Scholar]
  13. Wienecke R., Schlüpen E. M., Zöchling N., Neubert U., Meurer M., Volkenandt M. No evidence for Borrelia burgdorferi-specific DNA in lesions of localized scleroderma. J Invest Dermatol. 1995 Jan;104(1):23–26. doi: 10.1111/1523-1747.ep12613456. [DOI] [PubMed] [Google Scholar]
  14. von Stedingk L. V., Olsson I., Hanson H. S., Asbrink E., Hovmark A. Polymerase chain reaction for detection of Borrelia burgdorferi DNA in skin lesions of early and late Lyme borreliosis. Eur J Clin Microbiol Infect Dis. 1995 Jan;14(1):1–5. doi: 10.1007/BF02112610. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES